Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Avantor ( (AVTR) ) just unveiled an announcement.
On July 21, 2025, Avantor announced the appointment of Emmanuel Ligner as its new President and CEO, effective August 18, 2025. Ligner, with over 30 years of experience in the life sciences industry, succeeds Michael Stubblefield and is expected to drive competitive growth and value in Avantor’s Lab Solutions and Bioscience Production sectors.
The most recent analyst rating on (AVTR) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Avantor stock, see the AVTR Stock Forecast page.
Spark’s Take on AVTR Stock
According to Spark, TipRanks’ AI Analyst, AVTR is a Neutral.
Avantor’s overall score reflects solid financial management and operational efficiency, tempered by revenue challenges and mixed market signals. The company’s strategic initiatives to reduce costs and expand margins show promise, but market pressures and leadership transitions pose risks. Technical indicators suggest cautious investor sentiment, while fair valuation supports stability.
To see Spark’s full report on AVTR stock, click here.
More about Avantor
Avantor is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The company supports breakthroughs in medicine, healthcare, and technology across more than 300,000 customer locations in 180 countries.
Average Trading Volume: 12,646,428
Technical Sentiment Signal: Sell
Current Market Cap: $9.06B
For detailed information about AVTR stock, go to TipRanks’ Stock Analysis page.